Recipient risk factors for graft failure in the cornea donor study.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMC 2740901)

Published in Ophthalmology on April 23, 2009

Authors

Alan Sugar1, Jean Paul Tanner, Mariya Dontchev, Brad Tennant, Robert L Schultze, Steven P Dunn, Thomas D Lindquist, Robin L Gal, Roy W Beck, Craig Kollman, Mark J Mannis, Edward J Holland, Cornea Donor Study Investigator Group

Author Affiliations

1: W. K. Kellogg Eye Center, The University of Michigan, Ann Arbor, Michigan, USA. cds@jaeb.org

Articles citing this

Descemet's stripping automated endothelial keratoplasty outcomes compared with penetrating keratoplasty from the Cornea Donor Study. Ophthalmology (2010) 1.86

Donor age and factors related to endothelial cell loss 10 years after penetrating keratoplasty: Specular Microscopy Ancillary Study. Ophthalmology (2013) 1.28

Graft survival and endothelial outcomes in the new era of endothelial keratoplasty. Exp Eye Res (2011) 1.07

Effect of donor and recipient factors on corneal graft rejection. Cornea (2012) 1.05

Baseline factors related to endothelial cell loss following penetrating keratoplasty. Arch Ophthalmol (2011) 1.01

Alterations in the aqueous humor proteome in patients with a glaucoma shunt device. Mol Vis (2011) 0.98

Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study. Cornea (2014) 0.94

Factors associated with corneal graft survival in the cornea donor study. JAMA Ophthalmol (2015) 0.94

Ocular surface rehabilitation: Application of human amniotic membrane in high-risk penetrating keratoplasties. Saudi J Ophthalmol (2014) 0.85

Corneal thickness as a predictor of corneal transplant outcome. Cornea (2013) 0.83

Endothelial morphometric measures to predict endothelial graft failure after penetrating keratoplasty. JAMA Ophthalmol (2013) 0.82

Five-year outcomes of eyes with glaucoma drainage device and penetrating keratoplasty. J Glaucoma (2012) 0.81

Perioperative and postoperative risk factors for corneal graft failure. Clin Ophthalmol (2014) 0.80

Descemet stripping with automated endothelial keratoplasty: A comparative study of outcome in patients with preexisting glaucoma. Saudi J Ophthalmol (2013) 0.78

Cornea preservation time study: methods and potential impact on the cornea donor pool in the United States. Cornea (2015) 0.78

Increased Rates of Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Graft Failure and Dislocation in Glaucomatous Eyes with Aqueous Shunts. J Ophthalmic Vis Res (2012) 0.78

Boston type 1 keratoprosthesis for failed keratoplasty. Int Ophthalmol (2015) 0.77

Murine corneal transplantation: a model to study the most common form of solid organ transplantation. J Vis Exp (2014) 0.77

Results of excimer laser penetrating keratoplasty in aphakic eyes. Graefes Arch Clin Exp Ophthalmol (2012) 0.77

Distinctive and pervasive alterations in aqueous humor protein composition following different types of glaucoma surgery. Mol Vis (2015) 0.76

Outcomes of Descemet Membrane Endothelial Keratoplasty in Patients With Previous Glaucoma Surgery. Cornea (2016) 0.75

Endothelial graft failure after contralateral autologous corneal transplantation. Cornea (2013) 0.75

Age-Stratified Analysis of Diabetes and Pseudophakia Effects on Corneal Endothelial Cell Density: A Retrospective Eye Bank Study. Cornea (2016) 0.75

Articles cited by this

The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol (1992) 3.18

Long-term graft survival after penetrating keratoplasty. Ophthalmology (2003) 2.53

The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19

Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology (1994) 2.01

Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94

Baseline donor characteristics in the Cornea Donor Study. Cornea (2005) 1.92

Clinical profile and early surgical complications in the Cornea Donor Study. Cornea (2006) 1.77

How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation (2006) 1.40

Long-term results after penetrating keratoplasty for Fuchs' endothelial dystrophy. Arch Ophthalmol (1996) 1.38

Design and methods of The Collaborative Corneal Transplantation Studies. The Collaborative Corneal Transplantation Studies Research Group. Cornea (1993) 1.27

Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol (2003) 1.22

The influence of glaucoma history on graft survival after penetrating keratoplasty. Graefes Arch Clin Exp Ophthalmol (1997) 1.03

Corneal endothelial cell loss after nonmechanical penetrating keratoplasty depends on diagnosis: a regression analysis. Graefes Arch Clin Exp Ophthalmol (2002) 1.02

An analysis of corneal endothelial and graft survival in pseudophakic bullous keratopathy. Trans Am Ophthalmol Soc (1989) 0.95

Bullous keratopathy: a study of endothelial cell morphology in patients undergoing cataract surgery. Br J Ophthalmol (1988) 0.89

Articles by these authors

Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet (2010) 6.50

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79

A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol (2003) 5.27

The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood (2004) 4.91

A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology (2003) 4.88

Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol (2005) 4.38

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49

A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology (2004) 3.48

The IC3D classification of the corneal dystrophies. Cornea (2008) 3.46

Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol (2005) 3.42

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ (2011) 3.36

Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol (2007) 3.18

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol (2003) 3.13

The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care (2007) 3.11

Continuous glucose monitoring in children with type 1 diabetes. J Pediatr (2007) 3.06

Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98

Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther (2005) 2.98

Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol (2011) 2.91

Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology (2006) 2.89

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care (2009) 2.85

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84

Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83

Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care (2013) 2.73

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68

Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes (2005) 2.64

A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care (2005) 2.59

Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology (2007) 2.58

Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care (2014) 2.53

A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology (2006) 2.51

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology (2006) 2.43

Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes (2008) 2.41

Retinal nerve fiber layer thickness in amblyopic eyes. Am J Ophthalmol (2009) 2.29

A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol (2008) 2.26

A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care (2011) 2.26

The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19

Corneal transplantation. Lancet (2012) 2.13

Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. J Cataract Refract Surg (2012) 2.08

Pressure-induced interface keratitis: a late complication following LASIK. Cornea (2004) 2.03

Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care (2013) 2.03

Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care (2006) 2.02

Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology (2010) 2.02

Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes. Diabetes Care (2009) 2.01

Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol (2004) 2.01

Single-Pass Microkeratome System for Eye Bank DSAEK Tissue Preparation: Is Stromal Bed Thickness Predictable and Reproducible? Cornea (2016) 1.98

The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95

Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94

Baseline donor characteristics in the Cornea Donor Study. Cornea (2005) 1.92

Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab (2013) 1.92

Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther (2006) 1.89

Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials. J AAPOS (2009) 1.89

Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol (2008) 1.87

Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care (2012) 1.84

Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology (2011) 1.83

Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol (2008) 1.81

Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol (2008) 1.80

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood (2002) 1.79

Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes (2013) 1.78

Clinical profile and early surgical complications in the Cornea Donor Study. Cornea (2006) 1.77

Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old. Am J Ophthalmol (2003) 1.76

Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther (2005) 1.75

Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors. Diabetes Technol Ther (2005) 1.74

Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology (2007) 1.73